Christian Mallen c.d.mallen@keele.ac.uk
Temporal relationships between systemic lupus erythematosus and comorbidities
Mallen
Authors
Abstract
Objective
To examine the burden of comorbidities prior to and after the diagnosis of SLE and its impact on mortality.
Methods
We identified 1605 incident cases of SLE and 6284 matched controls from the UK primary care. The risks of comorbidities before (prevalence; odds ratios) and after SLE diagnosis (incidence; hazard ratios) and the impact of comorbidities at diagnosis on all-cause mortality were estimated.
Results
At diagnosis, SLE was associated with adjusted odds ratios (95% CI) of 2.25 (1.97–2.56), 3.37 (2.49–4.57) and 3.54 (1.89–6.63) for a Charlson comorbidity index of 1–2, 3–4 and =5, respectively. Following diagnosis, SLE also associated with increased risk of developing any comorbidity with an adjusted hazard ratio (95% CI) of 1.30 (95% CI, 1.13–1.49). At diagnosis, SLE was associated with a greater risk of cancer, cardiovascular, renal, liver, rheumatological and neurological diseases as well as depression, anaemia and psoriasis. Risks of developing incident comorbidity in the categories of neoplasm, cardiovascular, genitourinary, metabolic/endocrine, gastrointestinal and hepatic diseases, chronic pulmonary diseases, musculoskeletal/connective tissue and neurological diseases were higher in SLE patients. People with SLE had higher mortality risk compared with controls, with adjusted hazard ratio of 1.91 (95% CI, 1.62–2.26); after further adjusting for comorbidities this reduced to 1.64 (1.37–1.97). Comorbidities at SLE diagnosis accounted for 27.6% of the apparent difference in mortality between SLE patients and matched controls.
Conclusion
People with SLE have increased risks of multiple comorbidities both prior to and after diagnosis and this contributes significantly to all-cause mortality.
Citation
Mallen. (2019). Temporal relationships between systemic lupus erythematosus and comorbidities. Rheumatology, 840-848. https://doi.org/10.1093/rheumatology/key335
Acceptance Date | Sep 8, 2018 |
---|---|
Publication Date | May 1, 2019 |
Journal | Rheumatology |
Print ISSN | 1462-0324 |
Publisher | Oxford University Press |
Pages | 840-848 |
DOI | https://doi.org/10.1093/rheumatology/key335 |
Keywords | systemic lupus erythematosus, comorbidities, temporal relationships, all-cause mortality, Charlson comorbidity index, epidemiology |
Publisher URL | https://doi.org/10.1093/rheumatology/key335 |
Files
Tables_and_figure_22Aug2018.pdf
(787 Kb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by-nc/4.0/
Comorbidities_SLE_21Aug2018 revision.pdf
(646 Kb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by-nc/4.0/
Fig1.tif
(204 Kb)
Other
Publisher Licence URL
https://creativecommons.org/licenses/by-nc/4.0/
You might also like
Downloadable Citations
About Keele Repository
Administrator e-mail: research.openaccess@keele.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search